SERPINE1 and skin squamous cell carcinoma: Taken together, these findings suggest that inhibition of PAI-1 in cSCC may enhance the abscopal effect of radioimmunotherapy and prevent resistance to cytotoxic chemotherapeutic agents, indicating that PAI-1 could represent a promising therapeutic target in cSCC.